Conversely, the down-regulation of Wnt2b/β-linked protein expression through the use of Toll-like receptor 9 (TLR9) agonist CpG ODN has been shown to inhibit M2-like TAM polarization and exert anti-tumor effects [72]. This evidence concerns the gene TLR9 and neoplasm.